8 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... Anticoagulation #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology ... #Oncology
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... ” an infant with ... Procalcitonin <0.5 ng/mL ... Management #Pediatrics #Peds ... #Febrile #Infant
The Febrile Infant Step-by-Step Algorithm
This is an algorithm developed by European emergency physicians to identify low-risk
The Febrile Infant ... to identify low-risk ... empiric antibiotic treatment ... Management #Pediatrics #Peds ... #Antibiotics #Risk
Crohn's Disease & New Diagnosis of Colon Cancer Algorithm
 - Define Colonic Disease Extent, Activity &
of Colon Cancer Algorithm ... Consult CRS, Medical Oncology ... - ↑ rates intact ... Colon #Cancer #algorithm ... #management #treatment
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
Hodgkin Lymphoma Risk ... classical HL (MCHL ... Hodgkin Lymphoma Treatment ... classification #hematology ... #oncology #management
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
carries a variable risk ... Myelogenous Leukemia (CML ... and reducing the risk ... Syndromes #diagnosis #hematology ... #oncology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
PV, MDS, CML) Treatment ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... Thrombocythemia #ET #hematology